| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 245,569 | 455,094 | 1,387,112 | 1,100,780 | | Cost of Revenue | 160,770 |
-
| 1,080,744 | 818,573 | | | Gross Profit | 84,799 | 455,094 | 306,368 | 282,207 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (30,975) | 143,001 | 70,220 | 61,525 | | Non Recurring | 84,218 |
-
| 274,705 |
-
| | Others | 74,009 | 79,750 | 95,598 | 81,655 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (42,453) | 232,343 | (134,155) | 139,027 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 143,018 | 52,669 | (441,941) | 27,501 | | Earnings Before Interest And Taxes | 119,305 | 289,311 | (571,101) | 153,179 | | Interest Expense | 83,049 | 92,932 | 88,718 | 83,327 | | Income Before Tax | 36,256 | 196,379 | (659,819) | 69,852 | | Income Tax Expense | 3,806 | 15,361 | (568) | 22,319 | | Minority Interest | (494) | (310) | (8,347) | 1,031 | | | | Net Income From Continuing Ops | 31,956 | 180,708 | (659,251) | 47,533 | | | Non-recurring Events | | Discontinued Operations | 213,278 | 4,393 | (221,462) | 2,272 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 245,234 | 185,101 | (880,713) | 49,805 | | Preferred Stock And Other Adjustments | (6,369) | (6,369) | (6,352) | (6,333) | | | Net Income Applicable To Common Shares | $238,865 | $178,732 | ($887,065) | $43,472 |
|
0.17% Nasdaq 0.00%
Income Statement
